Search

Becton Dickinson and Co

Abierto

SectorSanidad

198.22 -0.39

Resumen

Variación precio

24h

Actual

Mínimo

196.74

Máximo

199.84

Métricas clave

By Trading Economics

Ingresos

759M

449M

Ventas

269M

5B

P/B

Media del Sector

46.209

50.373

BPA

3.23

Rentabilidad por dividendo

2.11

Margen de beneficios

9.011

Empleados

72,000

EBITDA

540M

1.2B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

-3.42% downside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

2.11%

2.12%

Próximas Ganancias

5 nov 2026

Fecha Próximo Dividendo

30 dic 2026

Próxima Fecha de Ex Dividendo

7 dic 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

7.9B

53B

Apertura anterior

198.61

Cierre anterior

198.22

Becton Dickinson and Co Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 nov 2026, 22:41 UTC

Becton Dickinson and Co's shares are advancing in after-market trading, supported by a significant rise in the Health Care Equipment sub-sector.

31 oct 2026, 00:01 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, reaching its highest level of the day and well above its 20-day moving average.

30 oct 2026, 21:51 UTC

Becton Dickinson and Co shares advanced modestly in after-market trading, continuing a strong performance that began shortly after the market closed.

29 oct 2026, 23:01 UTC

Becton Dickinson and Co shares are lower in after-market hours, reflecting broader market declines despite stronger-than-expected Q3 GDP growth.

28 oct 2026, 20:13 UTC

Becton Dickinson and Co shares advanced modestly in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

27 oct 2026, 19:16 UTC

Becton Dickinson and Co shares are declining, marking three consecutive lower daily closes, despite earlier rebounding from a session low.

26 oct 2026, 20:13 UTC

Becton Dickinson and Co's shares traded modestly lower during after-market hours on Monday, following a period of relative stability since the market closed.

24 oct 2026, 00:02 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month trading range.

23 oct 2026, 23:21 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month trading range.

22 oct 2026, 23:01 UTC

Becton Dickinson and Co shares fell in after-market trading, now at their lowest point of the day, moving lower since Thursday's close.

21 oct 2026, 19:56 UTC

Becton Dickinson and Co is experiencing a modest increase, currently positioned above its 20-day moving average and near the upper end of its one-month range.

20 oct 2026, 23:21 UTC

Correlated Moves

Becton Dickinson shares declined in after-market hours, influenced by disappointing earnings from holdings like Intuitive Surgical and Abbott Laboratories, amid broader sector weakness.

19 oct 2026, 22:21 UTC

Becton Dickinson and Co's shares rose in after-market trading, closing near session highs and reflecting a cumulative gain since Monday's close.

17 oct 2026, 00:01 UTC

Becton Dickinson and Co shares are modestly lower in after-market trading following a drop shortly after Friday's close.

16 oct 2026, 23:11 UTC

Becton Dickinson and Co shares are modestly lower in after-market trading, continuing a gradual decline from Friday's close while remaining above the 20-day moving average.

15 oct 2026, 20:02 UTC

Becton Dickinson and Co's shares are advancing amid significant gains in the Health Care Equipment sub-sector, remaining well above their 20-day moving average.

14 oct 2026, 23:51 UTC

Becton Dickinson shares are lower in after-market trading, reflecting a broader market decline amid renewed losses in semiconductor stocks and rising inflation concerns.

13 oct 2026, 19:46 UTC

Becton Dickinson and Co shares fell modestly after an early peak, reflecting typical performance for this time of day, while remaining above the 20-day moving average.

12 oct 2026, 22:01 UTC

Becton Dickinson and Co. shares declined modestly during after-market hours, continuing earlier losses amid unusual volatility and fluctuations in trading activity.

8 oct 2026, 20:01 UTC

News

Becton Dickinson advocates for reducing maternal mortality rates at the UN General Assembly, emphasizing advanced monitoring technologies for childbirth complications.

7 oct 2026, 19:50 UTC

News

Becton Dickinson shares fell sharply after Barclays initiated coverage with an Underweight rating and set a price target of $165, overshadowing positive trial results.

6 oct 2026, 21:51 UTC

News

Becton Dickinson and Co shares declined in after-market trading after Barclays initiated coverage with an Underweight rating and a $165.00 price target.

5 oct 2026, 20:31 UTC

Becton Dickinson and Co is experiencing a deeper decline in after-market trading, now modestly lower since Monday's close and near the lower end of its one-month range.

2 oct 2026, 19:26 UTC

Becton Dickinson and Co shares fell, continuing a trend of weaker closes over the past four sessions, remaining significantly below their 20-day moving average.

1 oct 2026, 20:07 UTC

Becton Dickinson and Co's shares fell, marking a fourth consecutive day of declines, closing below Wednesday's level and its 20-day moving average.

30 sept 2026, 20:20 UTC

Becton Dickinson and Co is trading modestly lower in after-market hours, continuing a decline below its recent trend and significantly under its 20-day moving average.

29 sept 2026, 20:07 UTC

Becton Dickinson and Co's shares are declining, reflecting a broader market trend, despite an earlier rebound from a session low.

28 sept 2026, 19:15 UTC

Becton Dickinson and Co shares fell slightly, trading around the midpoint of their one-month range after fluctuating earlier in the session.

25 sept 2026, 22:55 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, reflecting upward movement from Friday's close, amid flat U.S. durable goods orders for August.

24 sept 2026, 19:06 UTC

Becton Dickinson and Co shares fell sharply, reversing from an earlier peak and currently near the low end of their one-month range.

Comparación entre iguales

Cambio de precio

Becton Dickinson and Co previsión

Precio Objetivo

By TipRanks

-3.42% descenso

Estimación a 12 Meses

Media 191.8 USD  -3.42%

Máximo 210 USD

Mínimo 165 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Becton Dickinson and Co Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

4

Comprar

5

Mantener

1

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
help-icon Live chat